Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.62 USD | -10.44% | -7.47% | -27.94% |
20/06 | Disc Medicine Insider Bought Shares Worth $3,000,024, According to a Recent SEC Filing | MT |
17/06 | BMO Capital Adjusts Price Target on Disc Medicine to $70 From $50, Maintains Outperform Rating | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
137.86Cr | - | - | - | - | - | |
4.44TCr | - | |||||
3.8TCr | ||||||
3.78TCr | ||||||
3.08TCr | - | |||||
2.74TCr |
- Stock Market
- Equities
- IRON Stock
- Charts Disc Medicine, Inc.
- Sector Chart